These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9707608)

  • 1. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
    Sylla BS; Hung SC; Davidson DM; Hatzivassiliou E; Malinin NL; Wallach D; Gilmore TD; Kieff E; Mosialos G
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10106-11. PubMed ID: 9707608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
    Song YJ; Kang MS
    Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40.
    Luftig MA; Cahir-McFarland E; Mosialos G; Kieff E
    J Biol Chem; 2001 May; 276(18):14602-6. PubMed ID: 11278268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
    Luftig M; Prinarakis E; Yasui T; Tsichritzis T; Cahir-McFarland E; Inoue J; Nakano H; Mak TW; Yeh WC; Li X; Akira S; Suzuki N; Suzuki S; Mosialos G; Kieff E
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15595-600. PubMed ID: 14673102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.
    Geleziunas R; Ferrell S; Lin X; Mu Y; Cunningham ET; Grant M; Connelly MA; Hambor JE; Marcu KB; Greene WC
    Mol Cell Biol; 1998 Sep; 18(9):5157-65. PubMed ID: 9710600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
    Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
    Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of NF-kappaB-inducing kinase action.
    Lin X; Mu Y; Cunningham ET; Marcu KB; Geleziunas R; Greene WC
    Mol Cell Biol; 1998 Oct; 18(10):5899-907. PubMed ID: 9742107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
    Wu L; Nakano H; Wu Z
    J Biol Chem; 2006 Jan; 281(4):2162-9. PubMed ID: 16280329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells.
    Maeda S; Yoshida H; Ogura K; Mitsuno Y; Hirata Y; Yamaji Y; Akanuma M; Shiratori Y; Omata M
    Gastroenterology; 2000 Jul; 119(1):97-108. PubMed ID: 10889159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
    Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
    Kung CP; Raab-Traub N
    J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions.
    O'Mahony A; Lin X; Geleziunas R; Greene WC
    Mol Cell Biol; 2000 Feb; 20(4):1170-8. PubMed ID: 10648602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
    Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
    Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
    Fries KL; Miller WE; Raab-Traub N
    Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
    Saito N; Courtois G; Chiba A; Yamamoto N; Nitta T; Hironaka N; Rowe M; Yamamoto N; Yamaoka S
    J Biol Chem; 2003 Nov; 278(47):46565-75. PubMed ID: 12968033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.